Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The ...

Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Petrol prices in the UAE could rise for the month of November when the Fuel Price Committee will announce revised rates on Thursday. For the month of October, prices were revised down for the ...

But most people who buy coverage from HealthCare.gov or a state marketplace don't pay the full monthly cost for health insurance. More than 90% of health insurance plans from HealthCare.gov or state ...

Furthermore, for large industrial consumers, prices are often negotiated at wholesale, rather than retail markets. In 2023, Cyprus and Hungary had some of the highest electricity prices for ...

Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding ...

Study results in September showed that approach could improve upon standard immunotherapy treatments, like Merck & Co.’s Keytruda. Drugs targeting PD-1 and VEGF have since drawn the interest of an ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...